Since the results of logistic regression indicated CLASP2 and E-cadherin mRNA levels in tumor and urine were risk factors for progression of bladder cancer, the values of these biomarkers in discriminating the patients with 2-years progression from those without were further evaluated by ROC analysis. The gene discussed is CLASP2; the disease is urinary bladder carcinoma.